Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
NXTC — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

2.98

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

0.24

EPS Last/This Y

12.72

EPS This/Next Y

-1.42

Price

7.84

Target Price

19.33

Analyst Recom

1

Performance Q

-40.77

Upside

-3,266.2%

Beta

1.44

Ticker: NXTC



22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-23NXTC12.07N/AN/A0
2026-04-24NXTC10.8N/AN/A0
2026-04-27NXTC9.74N/AN/A0
2026-04-28NXTC9.495N/AN/A0
2026-04-29NXTC8.97N/AN/A0
2026-04-30NXTC9.42N/AN/A0
2026-05-01NXTC9.65N/AN/A0
2026-05-04NXTC9.01N/AN/A0
2026-05-05NXTC9.43N/AN/A0
2026-05-06NXTC10.54N/AN/A0
2026-05-07NXTC10.17N/AN/A0
2026-05-08NXTC10N/AN/A0
2026-05-11NXTC9.74N/AN/A0
2026-05-12NXTC9.9N/AN/A0
2026-05-13NXTC9.86N/AN/A0
2026-05-14NXTC10.11N/AN/A0
2026-05-15NXTC9.83N/AN/A0
2026-05-18NXTC9.32N/AN/A0
2026-05-19NXTC9.13N/AN/A0
2026-05-20NXTC9.81N/AN/A0
2026-05-21NXTC10.13N/AN/A0
2026-05-22NXTC7.84N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1



21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-23NXTC12.2361.345.0-8.21
2026-04-24NXTC10.4961.355.9-8.21
2026-04-27NXTC9.5761.362.5-8.21
2026-04-28NXTC9.4061.362.9-8.21
2026-04-30NXTC9.3161.363.2-8.21
2026-05-01NXTC9.4661.361.6-8.21
2026-05-04NXTC8.9661.365.9-8.21
2026-05-05NXTC9.4361.361.7-8.21
2026-05-06NXTC10.6061.357.7-8.21
2026-05-07NXTC10.0661.358.3-8.21
2026-05-08NXTC9.9361.359.3-8.21
2026-05-11NXTC9.8661.359.2-8.98
2026-05-12NXTC9.6256.6- -8.98
2026-05-13NXTC9.9056.6- -8.98
2026-05-14NXTC10.4856.6- -8.98
2026-05-15NXTC9.5156.6- -7.69
2026-05-18NXTC9.4183.7- -7.69
2026-05-19NXTC9.1783.7- -7.69
2026-05-20NXTC9.4383.5- -6.93
2026-05-21NXTC10.6083.5- -6.93
2026-05-22NXTC7.8483.5- -6.93
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1



22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-23NXTC0.0017.582.33
2026-04-24NXTC0.0017.582.33
2026-04-27NXTC0.0017.583.03
2026-04-28NXTC0.0017.583.03
2026-04-29NXTC0.0017.583.03
2026-04-30NXTC0.0017.583.03
2026-05-01NXTC0.0017.583.03
2026-05-04NXTC0.0017.333.03
2026-05-05NXTC0.0017.333.03
2026-05-06NXTC0.0017.333.03
2026-05-07NXTC0.0017.333.03
2026-05-08NXTC0.0017.333.03
2026-05-11NXTC0.0017.302.99
2026-05-12NXTC0.0017.302.99
2026-05-13NXTC0.0017.302.99
2026-05-14NXTC0.0017.302.99
2026-05-15NXTC0.0017.302.99
2026-05-18NXTC0.0017.162.98
2026-05-19NXTC0.0017.162.98
2026-05-20NXTC0.0017.162.98
2026-05-21NXTC0.0017.162.98
2026-05-22NXTC0.0017.162.98
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS​

-1.87

Avg. EPS Est. Current Quarter

-1.86

Avg. EPS Est. Next Quarter

-1.63

Insider Transactions

Institutional Transactions

17.16

Beta

1.44

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

3

Growth Score

18

Sentiment Score

92

Actual DrawDown %

92.9

Max Drawdown 5-Year %

-97

Target Price

19.33

P/E

Forward P/E

PEG

P/S

P/B

1.06

P/Free Cash Flow

EPS

-19.07

Average EPS Est. Cur. Y​

-6.93

EPS Next Y. (Est.)

-8.35

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

1.91

Return on Equity vs Sector %

-231.7

Return on Equity vs Industry %

-216.1

EPS 1 7Days Diff

0.8

EPS 1 30Days Diff

1.28

EBIT Estimation

◆ NXTC Healthcare
$7.83
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
20/20
Pullback
15/25
Volume
3/15
Valuation
12/20
TP/AR
2/10
Options
0/10
RSI
36.4
Range 1M
1.5%
🚀
Momentum Growth
Ride accelerating trends
N/A
44 /100
WEAK
Momentum
18/25
Growth
17/30
Estimates
0/20
Inst/Vol
9/15
Options
0/10
EPS Yr
62.7%
EPS NY
-13.9%
52W%
29%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +146.9% upside
Quality
2/30
Valuation
16/30
Growth
10/25
Stability
7/10
LT Trend
4/5
Upside
+146.9%
Quality
3
Click a card to see score breakdown Full Analysis →
NextCure, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 40
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company also develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. The company was incorporated in 2015 and is headquartered in Beltsville, Maryland.
NXTC

Latest News

—
Caricamento notizie per NXTC…
stock quote shares NXTC – Nextcure Inc Stock Price stock today
news today NXTC – Nextcure Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch NXTC – Nextcure Inc yahoo finance google finance
stock history NXTC – Nextcure Inc invest stock market
stock prices NXTC premarket after hours
ticker NXTC fair value insiders trading